Statistical analysis revealed that 80.4% of NSCLC specimens with high CD47 expression also exhibited strong Cdc42 staining signals, and 85.3% of the tumor samples with low CD47 expression displayed low or undetectable Cdc42 signals (X2 = 33.87, P < 0.01). The gene discussed is CD47; the disease is neoplasm.